Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.42) by 35.71 percent. The company reported quarterly sales of $3.29 million which beat the analyst consensus estimate of $2.08 million by 58.51 percent.
Posted In: CRVO